Your browser doesn't support javascript.
loading
International Care programs for Pediatric Post-COVID Condition (Long COVID) and the way forward.
Brackel, Caroline L H; Noij, Lieke C E; Vijverberg, Susanne J H; Legghe, Camille L; Maitland-van der Zee, Anke H; van Goudoever, Johannes B; Buonsenso, Danilo; Munblit, Daniel; Sigfrid, Louise; McFarland, Sammie; Anmyr, Lena; Ashkenazi-Hoffnung, Liat; Bellinat, Ana P N; Dias, Nathália L S; Edwards, Amy; Fashina, Tomini; Juraski, Romana Gjergja; Gonçalves, Ana L N; Hansted, Edita; Herczeg, Vivien; Hertting, Olof; Jankauskaite, Lina N; Kaswandani, Nastiti; Kevalas, Rimantas; Krivácsy, Péter; Lorenz, Michael; Malone, Laura A; McVoy, Molly; Miller, David W; Morrow, Amanda K; Nugawela, Manjula D; Oliveira, Carlos R; Oliveira, Pablo R S; Osmanov, Ismael M; Overmars, Isabella M; Paintsil, Elijah; Pinto Pereira, Snehal M; Prawira, Yogi; Putri, Nina Dwi; Ramos, Regina C F; Rasche, Marius; Ryd-Rinder, Malin; De Rose, Christina; Samitova, Elmira; Jovanovic, Tatjana Savic; Say, Daniela; Scott, Janet T; Shachar-Lavie, Iris; Shafran, Roz; Shmueli, Einat.
Afiliación
  • Brackel CLH; Department of Pediatric Pulmonology, Emma Children's Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands. C.l.brackel@amsterdamumc.nl.
  • Noij LCE; Department of Pediatrics, Tergooi MC, Hilversum, the Netherlands. C.l.brackel@amsterdamumc.nl.
  • Vijverberg SJH; Department of Pediatric Pulmonology, Emma Children's Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
  • Legghe CL; Department of Pediatric Pulmonology, Emma Children's Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
  • Maitland-van der Zee AH; Department of Pulmonary Medicine, Amsterdam Institute for Infection and Immunology, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
  • van Goudoever JB; Department of Pediatric Pulmonology, Emma Children's Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
  • Buonsenso D; Faculty of Pharmacy, University of Lille, Lille, France.
  • Munblit D; Department of Pediatric Pulmonology, Emma Children's Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
  • Sigfrid L; Department of Pulmonary Medicine, Amsterdam Institute for Infection and Immunology, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
  • McFarland S; Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
  • Anmyr L; Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Ashkenazi-Hoffnung L; Care for Long Term Conditions Division, Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.
  • Bellinat APN; Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Dias NLS; Research and Clinical Center for Neuropsychiatry, Moscow, Russia.
  • Edwards A; ISARIC Global Support Centre, Pandemic Science Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Fashina T; Long COVID Kids and Friends, Fletcher & Partners, Crown Chambers, Bridge Street, Salisbury, SP1 2LZ, UK.
  • Juraski RG; Medical Unit Social Work, Function Allied Health Professionals, Karolinska University Hospital, Stockholm, Sweden.
  • Gonçalves ALN; Department of Day Hospitalization, Schneider Children's Medical Center, Petach Tikva, Tel Aviv, Israel.
  • Hansted E; Pediatric Intensive Care Unit, Hospital Martagão Gesteira - Children's Hospital, Salvador, Brazil.
  • Herczeg V; Pediatric Intensive Care Unit, Hospital Martagão Gesteira - Children's Hospital, Salvador, Brazil.
  • Hertting O; Department of Infectious Disease, Rainbow Babies and Children's Hospital, Cleveland, OH, USA.
  • Jankauskaite LN; Department of Global Health, Yale University School of Public Health, New Haven, CT, USA.
  • Kaswandani N; Department of Pediatric Neurology, Srebrnjak Children's Hospital, Srebrnjak, Zagreb, Croatia.
  • Kevalas R; Medical School of Osijek, University of Osijek, Osijek, Zagreb, Croatia.
  • Krivácsy P; Universidade Católica de Pernambuco, Recife, Pernambuco, Brazil.
  • Lorenz M; Department of Pediatrics, Lithuanian University of Health Sciences Hospital KaunoKlinikos, Kaunas, Lithuania.
  • Malone LA; Pediatric Center, MTA Center of Excellence, Semmelweis University, Bókay Unit, Budapest, Hungary.
  • McVoy M; Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden.
  • Miller DW; Department of Pediatrics, Lithuanian University of Health Sciences Hospital KaunoKlinikos, Kaunas, Lithuania.
  • Morrow AK; Department of Child Health, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • Nugawela MD; Department of Pediatrics, Lithuanian University of Health Sciences Hospital KaunoKlinikos, Kaunas, Lithuania.
  • Oliveira CR; Pediatric Center, MTA Center of Excellence, Semmelweis University, Bókay Unit, Budapest, Hungary.
  • Oliveira PRS; Pediatric Pulmonology, Department of Paediatrics, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.
  • Osmanov IM; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Overmars IM; Department of Physical Medicine & Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Paintsil E; Kennedy Krieger Institute, Baltimore, MD, USA.
  • Pinto Pereira SM; Department of Pediatric Psychiatry, Rainbow Babies and Children's Hospital, Cleveland, OH, USA.
  • Prawira Y; Department of Pediatric Integrative Medicine, Rainbow Babies and Children's Hospital, Cleveland, OH, USA.
  • Putri ND; Department of Physical Medicine & Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Ramos RCF; UCL Great Ormond Street Institute of Child Health, London, UK.
  • Rasche M; Department of Pediatrics, Division of Infectious Diseases & Global Health, Yale University School of Medicine, New Haven, CT, USA.
  • Ryd-Rinder M; Institute of Biology, Federal University of Bahia, Salvador, Brazil.
  • De Rose C; ZA Bashlyaeva Children's Municipal Clinical Hospital, Moscow, Russia.
  • Samitova E; Pirogov Russian National Research Medical University, Moscow, Russia.
  • Jovanovic TS; Department of Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Melbourne, VIC, Australia.
  • Say D; Department of Pediatrics, Division of Infectious Diseases & Global Health, Yale University School of Medicine, New Haven, CT, USA.
  • Scott JT; Division of Surgery & Interventional Science, University College London, London, UK.
  • Shachar-Lavie I; Department of Child Health, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • Shafran R; Department of Child Health, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • Shmueli E; Hospital Universitário Oswaldo Cruz, Recife, Pernambuco, Brazil.
Pediatr Res ; 2024 Jan 29.
Article en En | MEDLINE | ID: mdl-38287106
ABSTRACT

BACKGROUND:

Pediatric Post-COVID-Condition (PPCC) clinics treat children despite limited scientific substantiation. By exploring real-life management of children diagnosed with PPCC, the International Post-COVID-Condition in Children Collaboration (IP4C) aimed to provide guidance for future PPCC care.

METHODS:

We performed a cross-sectional international, multicenter study on used PPCC definitions; the organization of PPCC care programs and patients characteristics. We compared aggregated data from PPCC cohorts and identified priorities to improve PPCC care.

RESULTS:

Ten PPCC care programs and six COVID-19 follow-up research cohorts participated. Aggregated data from 584 PPCC patients was analyzed. The most common symptoms included fatigue (71%), headache (55%), concentration difficulties (53%), and brain fog (48%). Severe limitations in daily life were reported in 31% of patients. Most PPCC care programs organized in-person visits with multidisciplinary teams. Diagnostic testing for respiratory and cardiac morbidity was most frequently performed and seldom abnormal. Treatment was often limited to physical therapy and psychological support.

CONCLUSIONS:

We found substantial heterogeneity in both the diagnostics and management of PPCC, possibly explained by scarce scientific evidence and lack of standardized care. We present a list of components which future guidelines should address, and outline priorities concerning PPCC care pathways, research and international collaboration. IMPACT Pediatric Post-COVID Condition (PPCC) Care programs have been initiated in many countries. Children with PPCC in different countries are affected by similar symptoms, limiting many to participate in daily life. There is substantial heterogeneity in diagnostic testing. Access to specific diagnostic tests is required to identify some long-term COVID-19 sequelae. Treatments provided were limited to physical therapy and psychological support. This study emphasizes the need for evidence-based diagnostics and treatment of PPCC. The International Post-COVID Collaboration for Children (IP4C) provides guidance for guideline development and introduces a framework of priorities for PPCC care and research, to improve PPCC outcomes.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Pediatr Res Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Pediatr Res Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos